Article
Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins.
Disease models & mechanisms - 1 Oct 2014
Jackrel Meredith E, Shorter James
Abstract excerpt
Protein misfolding is implicated in numerous lethal neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and Parkinson disease (PD). There are no therapies that reverse these protein-misfolding events. We aim to apply Hsp104, a hexameric AAA+ protein from yeast, to target misfolded conformers for reactivation. Hsp104 solubilizes disordered aggregates and amyloid, but has limited activity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
